June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Developing micro-RNAs as biomarkers for Primary Open Angle Glaucoma
Author Affiliations & Notes
  • Emmanuel S Buys
    Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
  • Allyson Hindle
    Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
  • Jessica V Jasien
    Ophthalmology, New York Eye and Ear Infirmary, New York, NY
  • Krishna Amin
    Qiagen, Frederick, MD
  • Kaitlin Allen
    Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
  • Ana Dordea
    Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
  • Sara Vandenwijngaert
    Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
  • Jasen Wise
    Qiagen, Frederick, MD
  • Jonathan Shaffer
    Qiagen, Frederick, MD
  • Robert Ritch
    Ophthalmology, New York Eye and Ear Infirmary, New York, NY
  • Footnotes
    Commercial Relationships Emmanuel Buys, None; Allyson Hindle, None; Jessica Jasien, None; Krishna Amin, Qiagen (E); Kaitlin Allen, None; Ana Dordea, None; Sara Vandenwijngaert, None; Jasen Wise, Qiagen (E); Jonathan Shaffer, Qiagen (E); Robert Ritch, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3654. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Emmanuel S Buys, Allyson Hindle, Jessica V Jasien, Krishna Amin, Kaitlin Allen, Ana Dordea, Sara Vandenwijngaert, Jasen Wise, Jonathan Shaffer, Robert Ritch; Developing micro-RNAs as biomarkers for Primary Open Angle Glaucoma. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3654.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Primary open angle glaucoma (POAG) often goes undetected, highlighting the need for novel diagnostic or treatment response biomarkers. A family of ~2500 noncoding microRNAs (miRNAs) function as key molecular regulators by repressing their target gene. miRNA-based therapeutics are promising strategies to treat and detect various disorders. Recent studies illustrated presence of ~500 miRNAs in aqueous humor (AqH). Limited data is available on differential miRNA levels in AqH from patients with various subtypes of POAG, or on the correlation between miRNAs in AqH and plasma. We aimed to identify miRNAs as potential POAG biomarkers in AqH and plasma.

 
Methods
 

AqH samples from 3 cataract patients (control), 3 POAG patients with peripheral visual field loss (PVFL), and 3 patients with early paracentral visual field loss, a POAG subtype associated with vascular dysregulation (ePaVFL), were analyzed on the Qiagen MIHS-3218Z platform (~1800 miRNAs). Subsequently, AqH samples from 4 control and 3 PVFL patients were analyzed on a custom-built array (CMIHS-02263) containing 372 miRNAs that were differentially expressed, highly abundant, or minimally variable on MIHS-3218Z. Finally, plasma and AqH samples from 3 control and 3 ePaVFL patients were analyzed on the Qiagen miFinder384HC platform. Supervised clustering by RandomForests detected best classifying miRNAs, and a linear mixed effects model controlling for “subject” as a random factor tested correlation in plasma versus AqH miRNA profiles.

 
Results
 

~800 unique miRNAs in 5ml AqH were identified on the MIHS-3218Z platform. Supervised clustering separated the three sample types and identified two miRNAs among the top classifying input variables (Fig. 1A,D). Similarly, CMIHS-02263 separately clustered control versus PVFL, using five top classifying miRNAs (Fig. 1B,E). Abundance of all assayed miRNAs was correlated between AqH and plasma in the same subjects (P<0.0001). Two input miRNAs were sufficient to completely separate the two sample types (Fig. 1C,F).

 
Conclusions
 

Our pilot study suggests that miRNAs are abundant in AqH from cataract and POAG patients and may be valuable diagnostic biomarkers for various subtypes of POAG. In addition, levels of miRNAs in plasma, a more readily accessible biomarker source than AqH, appear to correlate with AqH levels and allowed us to distinguish between cataract patients and ePaVFL patients.  

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×